The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly

Clinical Endocrinology

Volumn 75, Issue 2, 2011, Pages 220-225

  Jayasena, C N ^a   Comninos, A N ^a   Clarke, H ^a   Donaldson, M ^a   Meeran, K ^a   Dhillo, W S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHILD; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GROWTH HORMONE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 79960171994     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04019.x     Document Type: Article

References (32)

1. Holdaway, I.M., (2007) Excess mortality in acromegaly. Hormone Research, 68 (Suppl 5), 166-172.
2. Kauppinen-Makelin, R., Sane, T., Reunanen, A., et al. (2005) A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 4081-4086. (Pubitemid 41058176)
3. Holdaway, I.M., Rajasoorya, R.C., &, Gamble, G.D., (2004) Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 667-674. (Pubitemid 38269875)
4. Berg, C., Petersenn, S., Lahner, H., et al. (2009) Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. Journal of Clinical Endocrinology and Metabolism, 95, 3648-3656.
5. Giustina, A., Chanson, P., Bronstein, M.D., et al. (2010) A Consensus on Criteria for Cure of Acromegaly. Journal of Clinical Endocrinology and Metabolism, 95, 3141-3148.
6. Luger, A., Prager, R., Gaube, S., et al. (1990) Decreased peripheral insulin sensitivity in acromegalic patients. Experimental and Clinical Endocrinology, 95, 339-343. (Pubitemid 20303131)
7. Ho, K.K., Jenkins, A.B., Furler, S.M., et al. (1992) Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clinical Endocrinology (Oxford), 36, 271-279.
8. Wasada, T., Aoki, K., Sato, A., et al. (1997) Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy. Endocrine Journal, 44, 617-620. (Pubitemid 27406774)
9. Breidert, M., Pinzer, T., Wildbrett, J., et al. (1995) Long-term effect of octreotide in acromegaly on insulin resistance. Hormone and Metabolic Research, 27, 226-230.
10. Serri, O., Beauregard, C., &, Hardy, J., (2004) Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 658-661. (Pubitemid 38269873)
11. Alexopoulou, O., Bex, M., Abs, R., et al. (2008) Divergence between growth hormone and insulin-like growth factor-1 concentrations in the follow-up of acromegaly. Journal of Clinical Endocrinology and Metabolism, 93, 1324-1330. (Pubitemid 351519728)
12. Mercado, M., Espinosa de los Monteros, A.L., Sosa, E., et al. (2004) Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Hormone Research, 62, 293-299. (Pubitemid 40069628)
13. Bondanelli, M., Ambrosio, M.R., &, degli Uberti, E.C., (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary, 4, 239-249.
14. Jaffrain-Rea, M.L., Moroni, C., &, Baldelli, R., (2001) Relationship between blood pressure and glucose tolerance in acromegaly. Clinical Endocrinology (Oxford), 54, 189-195. (Pubitemid 32193520)
15. Barkan, A.L., (2001) Acromegalic arthropathy. Pituitary, 4, 263-264.
16. Alberti, K.G., &, Zimmet, P.Z., (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553. (Pubitemid 28319935)
17. Puder, J.J., Nilavar, S., Post, K.D., et al. (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 1972-1978. (Pubitemid 40590060)
18. Orme, S.M., McNally, R.J., Cartwright, R.A., et al. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism, 83, 2730-2734. (Pubitemid 28493768)
19. Colao, A., Ferone, D., Marzullo, P., et al. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews, 25, 102-152. (Pubitemid 38269977)
20. Lie, J.T., &, Grossman, S.J., (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal, 100, 41-52. (Pubitemid 10083045)
21. Colao, A., (2008) The GH-IGF-I axis and the cardiovascular system: clinical implications. Clinical Endocrinology, 69, 347-358.
22. Colao, A., Cuocolo, A., Marzullo, P., et al. (2001) Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism, 86, 1551-1557. (Pubitemid 32374902)
23. Colao, A., Spinelli, L., Cuocolo, A., et al. (2002) Cardiovascular consequences of early-onset growth hormone excess. Journal of Clinical Endocrinology and Metabolism, 87, 3097-3104. (Pubitemid 34822871)
24. Ito, H., Hiroe, M., Hirata, Y., et al. (1993) Insulin like growth factor 1 induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation, 87, 1715-1721. (Pubitemid 23133116)
25. Cannavo, S., Almoto, B., Cavalli, G., et al. (2006) Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. Journal of Clinical Endocrinology and Metabolism, 91, 3766-3772. (Pubitemid 44536841)
26. Otsuki, M., Kasamaya, S., Hiroyasu, Y., et al. (2001) Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clinical Endocrinology (Oxford), 16, 791-796. (Pubitemid 34211028)
27. Delafontaine, P., Lou, H., &, Alexander, R.W., (1991) Regulation of insulin-like growth factor 1 messenger RNA levels in vascular smooth muscle cells. Hypertension, 18, 742-747.
28. Colao, A., Spiezia, S., Cerbone, G., et al. (2001) Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clinical Endocrinology (Oxford), 54, 515-524. (Pubitemid 34204189)
29. Winer, L.M., Shaw, M.A., &, Baumann, G., (1990) Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. Journal of Clinical Endocrinology and Metabolism, 70, 1678-1686.
30. Gerich, J.E., Lorenzi, M., Bier, D.M., et al. (1976) Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. The Journal of Clinical Investigation, 57, 875-884.
31. Ahrén, K., Hjalmarson, A., &, Isaksson, O., (1969) Effects of growth hormone on amino acid transport and protein synthesis in the isolated working rat heart. Acta Physiologica Scandinavica, 76, 23A-24A.
32. Romero, C.J., Ng, Y., Luque, R.M., et al. (2010) Targeted Deletion of Somatotroph Insulin-Like Growth Factor-I Signaling in a Cell-Specific Knockout Mouse Model. Molecular Endocrinology, 24, 1077-1089.